Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Inflammation Mediators »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Inflammation < Inflammation Mediators < Inflammatory Bowel Diseases  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000134 (2020) Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne]Interleukin-6: A Masterplayer in the Cytokine Network.
000797 (2018) Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon]Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
000853 (2018) Aly M. Abdelrahman [Oman] ; Yousuf M. Al Suleimani [Oman] ; Mohammed Ashique [Oman] ; Priyadarsini Manoj [Oman] ; Badreldin H. Ali [Oman]Effect of infliximab and tocilizumab on fructose-induced hyperinsulinemia and hypertension in rats.
000B23 (2017) Takashi Matsuwaki [Japon] ; Kiseko Shionoya [Suède] ; Robert Ihnatko [Suède] ; Anna Eskilsson [Suède] ; Shigeru Kakuta [Japon] ; Sylvie Dufour [France] ; Markus Schwaninger [Allemagne] ; Ari Waisman [Allemagne] ; Werner Müller [Royaume-Uni] ; Emmanuel Pinteaux [Royaume-Uni] ; David Engblom [Suède] ; Anders Blomqvist [Suède]Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses.
000B81 (2017) C. Pérez-Sánchez [Espagne] ; P. Ruiz-Lim N [Espagne] ; M A Aguirre [Espagne] ; Y. Jiménez-G Mez [Espagne] ; I. Arias-De La Rosa [Espagne] ; M C Ábalos-Aguilera [Espagne] ; A. Rodriguez-Ariza [Espagne] ; M C Castro-Villegas [Espagne] ; R. Ortega-Castro [Espagne] ; P. Segui [Espagne] ; C. Martinez [Espagne] ; R. Gonzalez-Conejero [Espagne] ; S. Rodríguez-L Pez [Espagne] ; J A Gonzalez-Reyes [Espagne] ; J M Villalba [Espagne] ; E. Collantes-Estévez [Espagne] ; A. Escudero [Espagne] ; N. Barbarroja [Espagne] ; Ch L Pez-Pedrera [Espagne]Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.
000C37 (2017) Tao Li [États-Unis] ; Whayoung Lee ; Hidetaka Hara ; Cassandra Long ; Mohamed Ezzelarab ; David Ayares ; Hai Huang ; Yi Wang ; Charles T. Esmon ; David K C. Cooper ; Hayato IwaseAn Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.
000E21 (2016) Tadashi Okano [Japon] ; Kentaro Inui [Japon] ; Masahiro Tada [Japon] ; Yuko Sugioka [Japon] ; Kenji Mamoto [Japon] ; Shigeyuki Wakitani [Japon] ; Tatsuya Koike [Japon] ; Hiroaki Nakamura [Japon]Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
000E22 (2016) William G. Reiss [États-Unis] ; Jenny N. Devenport [États-Unis] ; Jason M. Low [États-Unis] ; George Wu [États-Unis] ; Eric H. Sasso [États-Unis]Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
000F26 (2016) Michele Maria Luchetti [Italie] ; Andrea Balloni ; Armando GabrielliBiologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile.
000F96 (2015) Sujin Kang [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]Therapeutic uses of anti-interleukin-6 receptor antibody.
001083 (2015) Andrea M. Griesinger [États-Unis] ; Rebecca J. Josephson [États-Unis] ; Andrew M. Donson [États-Unis] ; Jean M. Mulcahy Levy [États-Unis] ; Vladimir Amani [États-Unis] ; Diane K. Birks [États-Unis] ; Lindsey M. Hoffman [États-Unis] ; Steffanie L. Furtek [États-Unis] ; Phillip Reigan [États-Unis] ; Michael H. Handler [États-Unis] ; Rajeev Vibhakar [États-Unis] ; Nicholas K. Foreman [États-Unis]Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.
001193 (2015) Pietro Enea Lazzerini [Italie] ; Maurizio Acampa ; Pier Leopoldo Capecchi ; Irene Fineschi ; Enrico Selvi ; Valentina Moscadelli ; Stefania Zimbone ; Daniela Gentile ; Mauro Galeazzi ; Franco Laghi-PasiniAntiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation.
001219 (2014) Norihiro Nishimoto[Programs for continuing medical education: a session; 8. Pharmacotherapy of rheumatoid arthritis--interleukin-6 blocker made in Japan].
001237 (2014) Matthew L. Stoll [États-Unis] ; Randy Q. Cron [États-Unis]Treatment of juvenile idiopathic arthritis: a revolution in care.
001351 (2014) Ivan Caiello [Italie] ; Gaetana Minnone [Italie] ; Dirk Holzinger [Allemagne] ; Thomas Vogl [Allemagne] ; Giusi Prencipe [Italie] ; Antonio Manzo [Italie] ; Fabrizio De Benedetti [Italie] ; Raffaele Strippoli [Italie]IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
001415 (2014) Tetsuo Kobayashi [Japon] ; Moe Okada ; Satoshi Ito ; Daisuke Kobayashi ; Kohei Ishida ; Anri Kojima ; Ichiei Narita ; Akira Murasawa ; Hiromasa YoshieAssessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis.
001493 (2013) Luigi Muratori [Italie] ; Maria Serena LonghiThe interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.
001546 (2013) Peter N. Morcos [États-Unis] ; Xiaoping Zhang ; Christine Mcintyre ; Beate Bittner ; Lucy Rowell ; Zubair HussainPharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20.
001564 (2013) Augusto Vaglio [Italie] ; Maria G. Catanoso ; Lucia Spaggiari ; Luca Magnani ; Nicol Pipitone ; Pierluigi Macchioni ; Lia Pulsatelli ; Maria Nicastro ; Gabriella Becchi ; Domenico Corradi ; Annibale Versari ; Luigi Boiardi ; Carlo SalvaraniInterleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.
001598 (2013) Fabiola Atzeni [Italie] ; Maurizio Benucci ; Salvatore Sallì ; Sara Bongiovanni ; Laura Boccassini ; Piercarlo Sarzi-PuttiniDifferent effects of biological drugs in rheumatoid arthritis.
001682 (2012) K. Yamamoto [Allemagne] ; S. Rose-JohnTherapeutic blockade of interleukin-6 in chronic inflammatory disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Inflammation Mediators" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Inflammation Mediators" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Inflammation Mediators
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021